Skip to main content
. 2020 Jun 30;32(4):280–288. doi: 10.5021/ad.2020.32.4.280

Table 1. Comparison of study variables with positive and negative autologous serum and positive test groups.

Study variable ASST/APST ASST/APST+ ASST+/APST ASST+/ASST+ p-value
Patients counts (n=300) 175 12 57 56
Age 35.97±12.12 38.08±12.18 34.11±12.87 35.29±14.28 0.697
Sex 0.230
 Male 81 (46.3) 2 (16.7) 26 (45.6) 28 (50.0)
 Female 94 (53.7) 10 (83.3) 31 (54.4) 28 (50.0)
Duration (wk) 95.95±175.74 70.08±147.37 56.30±101.89 45.86±117.01 0.004*
Episode(s) of angioedema 11 (6.3) 2 (16.7) 11 (19.3) 11 (19.6) 0.005*
History of atopy 20 (11.4) 3 (25.0) 9 (15.8) 5 (8.9) 0.336
Treatment level 0.432
 1 142 (84.0) 11 (91.7) 50 (89.3) 51 (92.7)
 2 21 (12.4) 1 (8.3) 4 (7.1) 2 (3.6)
 3 3 (1.8) 0 (0.0) 2 (3.6) 0 (0.0)
 4 3 (1.8) 0 (0.0) 0 (0.0) 2 (3.6)
C3 (mg/dl) 111.37±18.88 103.37±13.58 104.64±20.42 108.41±22.22 0.497
C4 (mg/dl) 26.99±7.38 29.66±9.60 26.13±5.89 24.93±9.18 0.439
Total IgE (IU/ml) 262.60±368.57 163.50±140.86 225.72±201.72 173.23±116.62 0.598
Eosinophil count (%) 2.73±1.83 2.85±1.51 2.67±1.75 2.29±1.46 0.375
Platelet count (109/L) 253.96±54.03 234.00±50.58 259.43±51.44 257.63±65.84 0.313
Thyroid function test
 TSH (mU/L) 2.04±1.74 1.63±1.14 2.24±1.94 4.91±16.36 0.460
 T3 (ng/dl) 111.65±29.99 107.00±14.70 113.28±19.46 108.60±21.71 0.445
 Free T4 (ng/dl) 1.28±0.35 1.28±0.19 1.27±0.18 1.27±0.27 0.812
Thyroid antibodies
 Anti-TSH-R (U/L) 0.62±1.17 0.70±0.38 0.43±0.25 0.48±0.27 0.079
 Anti-TPO (IU/ml) 120.98±509.32 71.69±173.70 145.30±371.63 157.60±498.87 0.059
 Anti-TG (IU/ml) 71.07±279.95 29.68±39.15 32.88±45.84 71.67±186.24 0.593

Values are presented as number only, number (%), or mean±standard deviation. APST: autologous plasma skin test, ASST: autologous serum skin test, −: negative, +: positive, TG: thyroglobulin, TPO: thyroid peroxidase, TSH: thyroid stimulating hormone, TSH-R: thyroid stimulating hormone receptor, IgE: immunoglobuline E. *p-value of <0.05.